AstraZeneca Pharma Q4FY26 Results: Revenue Jumps 20%, Profit Slips 23%

AstraZeneca Pharma India posted a mixed Q4FY26 performance, with revenue rising strongly, although higher costs pulled profit lower.

The company posted a net profit of ₹44.88 crore in Q4FY26, down 22.95% year-on-year from ₹58.25 crore reported in the corresponding quarter last year. Despite the drop in earnings, AstraZeneca delivered robust top-line growth during the quarter.

AstraZeneca Pharma India shares ended Tuesday’s session at ₹8,984.05 apiece on the Bombay Stock Exchange, up 2.14% from the previous close, ahead of the earnings announcement.

Revenue Growth Driven By Core Therapy Segments

Revenue from operations rose 20.42% to ₹578.61 crore in the January–March quarter, compared with ₹480.48 crore in Q4FY25. The revenue expansion was driven by continued momentum across the company’s core therapy segments, particularly Oncology, Biopharmaceuticals, and Rare Disease, according to the company statement.

However, growth in expenses weighed on profitability. Total expenses climbed 27.36% to ₹525.34 crore during the quarter, reflecting a faster rise than revenue and putting pressure on margins.

Looking at the full financial year, AstraZeneca Pharma India delivered a notably stronger performance than last year.

The company’s net profit surged 62% year-on-year to ₹187.52 crore. Meanwhile, total revenue for FY26 increased 32.58% to ₹2,275.58 crore, highlighting sustained demand across its India business through the year.

Management said the annual growth was supported by continued traction in its speciality portfolio, especially within cancer therapies and rare disease treatments.

Also Read - Marksans Pharma Limited Q4 FY26 Results: PAT Jumps 64% To Reach ₹149 Crore

Board Recommends Final Dividend For FY26

Alongside the earnings release, the board recommended a final dividend of ₹36 per equity share with a face value of ₹2 each, translating to a 1,800% dividend payout for FY26.

The dividend proposal is subject to shareholder approval at the company’s upcoming annual general meeting.

Sources:

NDTV Profit

ETNow